SHERRY KOHN: Open Payments
NPI 1710291034 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,090 in 37 payments from 10 companies in 2025. Trend: 2023 $337 · 2024 $675 · 2025 $1,090
Food & beverage: $1,090
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 11 | $410 |
| Novo Nordisk Inc | 3 | $148 |
| KYOWA KIRIN, INC. | 5 | $123 |
| Alvogen Inc | 5 | $98 |
| Radius Health, Inc. | 3 | $76 |
| Corcept Therapeutics | 3 | $69 |
| Ascendis Pharma Endocrinology Inc | 2 | $57 |
| Lilly USA, LLC | 3 | $53 |
| Alexion Pharmaceuticals, Inc. | 1 | $32 |
| Neurocrine BioSciences, Inc. | 1 | $24 |
Products named: EVENITY, Wegovy, CRYSVITA, TERIPARATIDE, Korlym, Yorvipath, MOUNJARO, Tymlos.
Industry payments across NY — which companies pay providers there.
